Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.5754
-0.0246 (-4.10%)
At close: Jun 13, 2025, 4:00 PM
0.5909
+0.0155 (2.69%)
After-hours: Jun 13, 2025, 5:58 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $49.58 million as of June 13, 2025. Its market cap has decreased by -81.66% in one year.
Market Cap
49.58M
Enterprise Value
-62.87M
1-Year Change
-81.66%
Ranking
Category
Stock Price
$0.58
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $49.58M, a decrease of -95.28%. That is a compound annual growth rate of -53.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 49.58M | -42.27% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.99B |
| Johnson & Johnson | 376.94B |
| Novo Nordisk | 357.59B |
| AbbVie | 339.89B |
| UnitedHealth Group | 288.92B |
| Abbott Laboratories | 237.40B |
| Novartis AG | 236.22B |
| AstraZeneca | 232.37B |